Home / Inspections / 1010216

FDA Inspection 1010216 — Tris Pharma Inc.

Tris Pharma Inc. — FEI 3004712471

The FDA completed an inspection of Tris Pharma Inc. on March 20, 2017 in Monmouth Junction, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 20, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Monmouth Junction, NJ (United States)

Facility

Other inspections at this facility

  • 1289086 (VAI Fri Nov 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1232735 (VAI Fri Mar 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1143403 (VAI Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1076980 (OAI Wed Jan 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1048300 (VAI Mon Apr 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources